65 results
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements if not resolved to their satisfaction would … of shares subject to any lien, after payment of the costs, shall be applied:
first, in or towards satisfaction of so much of the amount due to the Company
424B7
IMCR
Immunocore Holdings plc
5 Apr 24
Prospectus with selling stockholder info
4:34pm
of a single transferee or no more than four joint transferees;
it is duly stamped or is duly certificated or otherwise shown to the satisfaction … as the depositary may deem reasonably appropriate, subject however, in each case, to satisfaction of the applicable registration requirements
PRE 14A
IMCR
Immunocore Holdings plc
2 Apr 24
Preliminary proxy
4:45pm
to their satisfaction would have caused them to make reference in connection with their opinion to the subject matter of the disagreement, and (2 … , shall be applied:
first, in or towards satisfaction of so much of the amount due to the Company or of the liability or engagement (as the case may
S-3ASR
IMCR
Immunocore Holdings plc
20 Mar 24
Automatic shelf registration
8:51pm
of a single transferee or no more than four joint transferees;
it is duly stamped or is duly certificated or otherwise shown to the satisfaction … and conditions as the depositary may deem reasonably appropriate, subject however, in each case, to satisfaction of the applicable registration requirements
10-K
2023 FY
EX-10.14
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
to comply and thirty (30) days to cure such failure to the Board’s reasonable satisfaction in its sole discretion; (iii) your committing any act which … ) days to cure such failure to Board’s reasonable satisfaction in its sole discretion; (v) your material breach of any provision of this Agreement, any
10-K
EX-10.12
8wakiosi9frvexb91
28 Feb 24
Annual report
7:33am
10-K
z8k9 53olrz
28 Feb 24
Annual report
7:33am
10-K
EX-10.13
pjqjkqdslz91p4f0
28 Feb 24
Annual report
7:33am
8-K
EX-4.1
hhe47wh6pimwtni72fl
2 Feb 24
Immunocore Prices Upsized Convertible Senior Notes Offering
4:05pm
8-K
EX-99.1
0mwr znxcnd5aw3ipd
2 Feb 24
Immunocore Prices Upsized Convertible Senior Notes Offering
4:05pm
8-K
EX-99.1
4hkj6tgg
29 Jan 24
Immunocore Announces Proposed Convertible Senior Notes Offering
5:06pm
6-K
EX-99.4
5tez47mximc4
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
424B7
8fpcwgs
30 Sep 22
Prospectus with selling stockholder info
4:15pm
6-K
EX-1.1
20nk8ly8k
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
424B5
ab2dn
9 Sep 22
Prospectus supplement for primary offering
4:23pm
6-K
shm1qtlyc
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.1
44h6e133xsnpt wur6
20 Jul 22
Securities Purchase Agreement
4:06pm
424B7
zuoydjvht0bo5xvq
5 May 22
Prospectus with selling stockholder info
12:00am
F-3ASR
EX-4.6
oe6i crfn1p4
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
F-3ASR
9sz2z1 75pdw
4 Apr 22
Automatic shelf registration (foreign)
4:08pm